Archive for the ‘IGIB’ Category
When Rajesh Gokhale sets up a new lab, he orders sophisticated equipment and some chemical reagents. For a research collaboration with the National Chemical Laboratory (NCL) in Pune, he ordered six buffaloes along with the regular stuff. He could have ordered elephants, but buffaloes were more manageable for the laboratory staff. These two animals have something in common. They get white patches on the skin, similar to the human disease leucoderma that Gokhale is now studying. Drug companies a ..
27 January 2013
It was once a large rectangular container used by a computer company to ship products. Now, the container, as large as a railway coach, is a clinic that may well define the future of healthcare in India.
14 November 2012
NEW DELHI: In a major breakthrough, doctors in the CSIR Institute of Genomics and Integrative Biology (IGIB) and AIIMS have discovered a neurological link to Diabetes 2.
Diabetes 2 is the most common type of diabetes and is rampant in India with 63 million Indians currently suffering from the disease caused by being overweight and due to lack of physical activity….
12 November 2012
MUMBAI: The Indian Diabetes Consortium (INDICO), a Pan-India initiative led by CSIR-Institute of Genomics and Integrative Biology (IGIB) with AIIMS as a principal clinical partner, has recently brought to light an entirely novel candidate gene, TMEM163 implicated in type 2 diabetes.
TMEM163 encodes a probable vesicular transporter in nerve terminals; and the study established a plausible mechanism of action for TMEM163 through impaired insulin secretion. This lends an unprecedented ‘neural angle’ to diabetes that needs to be explored further and holds immense potential in understanding new pathogenetic mechanisms involved in diabetes causation…..
19 September 2012
NEW DELHI: Pointing out that India has been overtaken in scientific research by other emerging powers, Prime Minister Manmohan Singh today asked scientists to seek newer frontiers of research, match capabilities of peers around the world and help India leapfrog.
Inaugurating the new campus of CSIR’s Institute of Genomics and Integrative Biology (IGIB) in south Delhi, he asked scientists to redouble efforts in research and development, a field where India has been overtaken by “other rapidly emerging powers”…….
17 September 2012
The country’s largest laboratory cluster – the Council of Scientific & Industrial Research (CSIR), with 38 labs across the country under its fold — is gearing up for its 70th birthday this week. It’s opening a new lab just across the one inaugurated by Jawaharlal Nehru back in the 1950s. The last time CSIR started a lab was a quarter century back. Besides the new lab that will focus on genomics research, this year marks a transformation that CSIR has never seen before. It has new focus areas, Medium Small & Micro Enterprises (MSME), CSIR is ready to undertake commercially-oriented research and plans to incubate and spin-off companies. “We are moving beyond Bharat Sarkar”, says an impassioned Samir K Brahmachari, director-general, CSIR, in a reference to its past. In an interview with Shelley Singh, Brahmachari talks about CSIR’s future.
18 September 2012
Not very far from Mall Road, where Rajesh Gokhale spends most of his time as director of the Institute of Genomics and Integrative Biology (IGIB), is the industrial area of Patparganj in Delhi. Located here is the two-year-old Vyome Biosciences, a startup by Gokhale and Harvard academic Shiladitya Sengupta that makes medicines for use in dermatology and wound healing.
It’s just a few minutes’ drive for Gokhale from IGIB to Vyome, but the distance he’s covered from being a scientist to an entrepreneur is no less than an epochal leap………….